MITA Expresses Concern to CMS About Proposed TCET Program
MITA expressed concern about the scope and utility of the proposed notice for the TCET program in its submitted comments to the CMS.
MITA expressed concern about the scope and utility of the proposed notice for the TCET program in its submitted comments to the CMS.
The Medical Imaging & Technology Alliance (MITA) announced that Richard Dewit of Bayer Healthcare will join its Board of Directors.
The Medical Imaging & Technology Alliance expressed disappointment with a Centers for Medicare & Medicaid Services proposal to withdraw the previously finalized Medicare Coverage of Innovative Technology rule.
MITA expressed concern about the scope and utility of the proposed notice for the TCET program in its submitted comments to the CMS.
The proposed PFS rule will lead to provider payment cuts for specialties that do not frequently bill E/M visits.
Read MoreWhen the pandemic first hit, many people incorrectly assumed that it would resolve quickly. And like COVID-19, there is another battle with seemingly no end in sight: the fight over access to vendor service manuals.
Read MoreThe Medical Imaging & Technology Alliance (MITA) has sent a letter in response to the U.S. Senate Committee on Health, Education, Labor, and Pensions’ white paper titled “Preparing for the Next Pandemic,” outling a series of recommendations.
Read MoreThe Alliance for Quality Medical Device Servicing, a group of six independent medical device service organizations, issued a statement expressing disappointment in the withdrawal of AdvaMed and MITA from the FDA-supported Medical Device Servicing Collaborative Communities.
Read MoreThe Medical Imaging & Technology Alliance (MITA) today applauded President Trump for signing a permanent repeal of the medical device tax into law.
Read MoreThe Medical Imaging & Technology Alliance (MITA) has commended U.S. lawmakers for including a permanent repeal of the medical device tax in the recently announced year-end government funding package.
Read MoreThe Medical Imaging & Technology Alliance (MITA) applauded a recent letter by U.S. senators Elizabeth Warren (D-Mass.) and Bill Cassidy (R-La.) to acting U.S. FDA Chairman Ned Sharpless, MD, about the agency’s upcoming guidance clarifying the distinction between the “servicing” and “remanufacturing” of medical devices.